Alembic releases generic CosoptGeneric Cosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. NACDS promotes Marilyn Hunter to VP, meetings and conferences Hunter has been promoted from her current role as senior director of meetings and conferences. Celltrion launches Stelara biosimilar Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well as Crohn's disease and ulcerative colitis in adult patients. APhA launches HealthShifts HealthShifts aims to address critical workforce challenges in pharmacy while promoting professional growth and career opportunities. Kinney Drugs raises awareness of colorectal screening Two non-invasive screening tests are available through Kinney Drugs. Surescripts releases 2024 Annual Impact Report The report reveals a double-digit increase in health intelligence sharing, measurably improving care quality, efficiency, access and affordability. IBSA USA debuts Irosolv Irosolv is an orally dissolving film strip supplement that contains iron and folic acid. Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval. CVS Weight Management program improves health outcomes, lowers costs As of Feb. 1, the CVS Weight Management program is available to more than 3.5 million CVS Caremark plan members. Mallinckrodt and Endo to merge Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the transaction. First Previous 3 4 5 6 7 Next Last
